FEOSPAN - Synonyme de

Numéro CAS : 7720-78-7

Identification

Description


Formule moléculaire brute : FeO4S

Principaux synonymes

Noms français :

  • Fer (II), sulfate de
  • Ferrosulfate
  • Ferrous sulfate
  • FERROUS SULFATE ANHYDROUS
  • IRON MONOSULFATE, ANHYDROUS
  • IRON(2+) SULFATE
  • IRON(II) SULFATE
  • MONOSULFATE DE FER
  • MONOSULFATE DE FER ANHYDRE
  • Sulfate de fer(II) anhydre
  • Sulfate ferreux
  • SULFATE FERREUX ANHYDRE

Noms anglais :

  • Ferrous sulfate
  • Ferrous sulphate
  • Iron monosulfate
  • Iron(II) sulfate, anhydrous
Utilisation et sources d'émission

Ce produit est utilisé comme :

  • agent réducteur:
  • catalyseur à polymérisation.

Références

  • ▲1.  Centre canadien d'hygiène et de sécurité au travail, CHEMINFO, Hamilton, Ont. : Canadian Centre for Occupational Health and Safety   http://ccinfoweb.ccohs.ca/cheminfo/search.html
  • ▲1.  Centre canadien d'hygiène et de sécurité au travail, CHEMINFO, Hamilton, Ont. : Canadian Centre for Occupational Health and Safety   http://ccinfoweb.ccohs.ca/cheminfo/search.html
  • ▲2.  National Institute for Occupational Safety and Health, NIOSH pocket guide to chemical hazards. 3 ed. Cincinnati, Ohio : NIOSH. (2007). [RM-514001]   https://www.cdc.gov/niosh/npg/default.html
  • ▲3.  Drolet, D. et Beauchamp, G, Guide d'échantillonnage des contaminants de l'air en milieu de travail. Études et recherches / Guide technique, 8ème éd. revue et mise à jour. Montréal : IRSST. (2012). T-06. [MO-220007]   http://www.irsst.qc.ca
    https://www.irsst.qc.ca/publications-et-outils/publication/i/384/n/guide-d-echantillonnage-des-contaminants-de-l-air-en-milieu-de-travail
  • ▲6.  Règlement sur la santé et la sécurité du travail [S-2.1, r. 13]. Québec : Éditeur officiel du Québec. [RJ-510071]   http://legisquebec.gouv.qc.ca/fr/ShowDoc/cr/S-2.1,%20r.%2013
  • ▲7.  ECHA (European Chemicals Agency) , Information on Chemicals (REACH). Helsinki, Finland.  

    http://echa.europa.eu/information-on-chemicals/registered-substances
    ECHA CHEM (europa.eu)


  • ▲8.  Bingham, E., Cohrssen, B. et Powell, C.H., Patty's toxicology. A Wiley-Interscience publication. New York (Toronto) : John Wiley. (2001-). [RM-214008]   http://www3.interscience.wiley.com (http://www3.interscience.wiley.com/cgi-bin/mrwhome/104554795/HOME)
  • ▲9.  Dreisbach, R.H. et Robertson, W.O., Handbook of poisoning: prevention diagnosis & treatment. 12th ed. Norwalk, Conn. : Appleton & Lange. (1987). [RM-515008]
  • ▲10.  Goodman, L.S. et al., Goodman & Gilman's : the pharmacological basis of therapeutics. 9th ed. New York : Montreal : Mc Graw-Hilll. (2001).
  • ▲11.  Schultz, R.L., «Placental transport: a review.» Obstetrical and Gynecological Survey. Vol. 25, no. 10, p. 979-1020. (1970). [AP-031205]
  • ▲12.  Heinonen, O. P., Shapiro, S. et Slone, D., Birth defect and drugs in pregnancy, Littleton, Massachusetts : Publishing Sciences Group, 1977 [MO-000066]
  • ▲13.  Coustan, D.R. et Mochizuki, T.K., Handbook for prescribing medications during pregnancy. 3rd ed. New York : Lippincott-Raven. (1998). [RM-015024]
  • ▲14.  Teratologic evaluation of FDA71-64 ferrous sulfate in mice and rats., 1974 Microfiche : PB-245 532, FDA/223-74-2176
  • ▲15.  Nelson, M. M. et Forfar, J. O., «Association between drugs administered during pregnancy and congenital abnormalities of the fetus», British Medical Journal, 1, 1971, 523-527 [ap-005780]
  • ▲16.  Linkenheimer, W. H., «The placental transfer of orally administered iron», Toxicology and Applied Pharmacology, 6, 1964, 669-675 [ap-043198]
  • ▲17.  Tadokoro, T., Miyaji, T. et Okumura, M., «Teratogenicity studies of Slow-Fe in mice and rats», Oyo Yakuri, 17, 1979, 483-495 [ap-005994]
  • ▲18.  Tenenbein, M., «Iron overdose during pregnancy», Veterinary and Human Toxicology, 31, 4, 1989, 346
  • ▲19.  Jensen, R.G., Handbook of milk composition. San Diego : Academic Press. (1995).
  • ▲20.  Blaque-Bélair, A., de Fossey, B.M. et Fourestier, M., Dictionnaire des constantes biologiques et physiques en médecine: applications cliniques pratiques. 6e éd. Paris : Éditions Maloine. (1991). [RM-019028]
  • ▲21.  Zapata, C. V., Donangelo, C. M. et Trufo, N. M. F., «Effect of iron supplementation during lactation on human milk composition», Journal of Nutritional Biochemistry, 5, 1994, 331-337 [ap-045340]
  • ▲22.  Ishidate, M. et al., «Primary mutagenicity screening of food additives currently used in Japan.» Food and Chemical Toxicology. Vol. 22, no. 8, p. 623-636. (1984). [AP-019737]
  • ▲23.  Whiting, R.F., Wei, L. et Stich, H.F., «Chromosome-damaging activity of ferritin and its relation to chelation and reduction of iron.» Cancer Research. Vol. 41, p. 1628-1636. (May 1981). [AP-010047]
  • ▲24.  Casto, B.C., Meyers, J. et DiPaolo, J.A., «Enhancement of viral transformation for evaluation of the carcinogenic or mutagenic potential of inorganic metal salts», Cancer Research, 39, 1979, 193-198 [AP-006678]
  • ▲25.  National Institute for Occupational Safety and Health, RTECS (Registry of Toxic Effects of Chemical Substances). Hamilton (Ont) : Canadian Centre for Occupational Health and Safety.   http://ccinfoweb.ccohs.ca/rtecs/search.html
  • ▲26.  Iron salts, water soluble. Health-based reassessment of administrative occupational exposure limits . The Hague : Health Council of the Netherlands. (2004). 2000/15OSH/102.   https://www.gezondheidsraad.nl/sites/default/files/0015102_0.pdf
  • ▲27.  Hoppe J.O., Marcelli G.M.A et Tainter M.L., «An experimental Study of the Toxicity of Ferrous Gluconate.» THE AMERICAN JOURNAL OF THE MEDICAL SCIENCES. Vol. 230, p. 491-498. (1955). [AP-025832]
  • ▲28.  Yeary R.A., Benish R.A. et Finkelstein M., «Acute Toxicity of Drugs in Newborn Animals.» Pediatric Pharmacology and Therapeutics. Vol. 69, no. 4, p. 663-666. (1966).

Autres sources d'information

  • Sax, N.I., Dangerous properties of industrial materials. 7th ed. Toronto : Van Nostrand Reinhold. (1989). [RR-014005]
  • Canutec. Guide de premières mesures d'urgence. Ottawa : Centre d'Édition du Gouvernement du Canada. (1986).
  • Kamboj V.P. et Kar A.B., «ANTITESTICULAR EFFECT OF METALLIC AND RARE EARTH SALTS.» Journal of Reproduction and Fertility. Vol. 7, p. 21-28. (1964). [AP-010383]
  • MAYO CLINIC PROCEEDINGS, VOL. 59, 1984, P. 707-716 [AP-010274]
  • PEDIATRIC PHARMACOLOGY AND THERAPEUTICS, VOL. 69, 1966, P. 663-667 [AP-018898]
  • CLINICAL AND PHARMACOLOGICAL THERAPY, VOL. 45, NO 3, 1989, P. 220-225 [AP-025607]
  • EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, VOL. 7, 1974, P. 357-360 [AP-025833]
  • JOURNAL OF PEDIATRICS, VOL. 94, NO 1, 1979, P. 147-149 [AP-025834]
  • American Journal of Hospital Pharmacy, VOL. 41, 1984, P. 1844-1848 [AP-010013]
  • British Medical Journal, VOL.1, 1971, P. 523-527 [AP-005780]
  • Madinaveitia, J.L., «Ferrocenes as haematinics.» British journal of pharmacology and chemotherapy. Vol. 24, p. 352-359. (1965). [AP-025819]
  • Gosselin, R.E., Hodge, H.C. et Smith, R.P., Clinical toxicology of commercial products. 5e éd. Baltimore (MD) : Williams & Wilkins. (1984). [RM-514002]
  • Goodman, L. S. et Gilman, A., Goodman and Gilman's : the pharmacological basis of therapeutics. 7th ed. New York : Toronto : Macmillan Pub. Co. ; Collier Macmillan Canada. (1985).

La cote entre [ ] provient de la banque Information SST du Centre de documentation de la CNESST.